Nang Kuang Pharmaceutical Co., Ltd. (1752.TW)
TWD 41.8
(2.45%)
TWD 41.8
(2.45%)
| Year | Eps | Eps Growth |
|---|---|---|
| 2023 | 1.96 TWD | -43.84% |
| 2022 | 3.49 TWD | 79.9% |
| 2021 | 1.94 TWD | 6.59% |
| 2020 | 1.82 TWD | -16.13% |
| 2019 | 2.17 TWD | 117.0% |
| 2018 | 1.00 TWD | -45.65% |
| 2017 | 1.84 TWD | -18.22% |
| 2016 | 2.25 TWD | 3.69% |
| 2015 | 2.17 TWD | 185.53% |
| 2014 | 0.76 TWD | 931.51% |
| 2013 | -0.09 TWD | -107.49% |
| 2012 | 1.22 TWD | 1120.0% |
| 2011 | 0.10 TWD | 158.82% |
| 2010 | -0.17 TWD | -185.0% |
| 2009 | 0.20 TWD | 0.0% |
| Year | Eps | Eps Growth |
|---|---|---|
| 2024 Q1 | 0.54 TWD | 258.82% |
| 2024 Q2 | 0.44 TWD | -18.52% |
| 2023 Q4 | -0.34 TWD | -173.91% |
| 2023 Q3 | 0.46 TWD | -50.0% |
| 2023 FY | - TWD | -43.84% |
| 2023 Q1 | 0.93 TWD | -41.88% |
| 2023 Q2 | 0.92 TWD | -1.08% |
| 2022 Q1 | 0.41 TWD | -19.61% |
| 2022 FY | - TWD | 79.9% |
| 2022 Q4 | 1.60 TWD | 116.22% |
| 2022 Q3 | 0.74 TWD | 0.0% |
| 2022 Q2 | 0.74 TWD | 80.49% |
| 2021 Q4 | 0.51 TWD | 13.33% |
| 2021 Q1 | 0.44 TWD | -6.38% |
| 2021 Q2 | 0.54 TWD | 22.73% |
| 2021 FY | - TWD | 6.59% |
| 2021 Q3 | 0.45 TWD | -16.67% |
| 2020 Q3 | 0.29 TWD | -32.56% |
| 2020 Q2 | 0.43 TWD | -30.65% |
| 2020 Q4 | 0.47 TWD | 62.07% |
| 2020 Q1 | 0.62 TWD | -22.5% |
| 2020 FY | - TWD | -16.13% |
| 2019 Q4 | 0.80 TWD | 33.33% |
| 2019 Q2 | 0.41 TWD | 17.14% |
| 2019 Q1 | 0.35 TWD | 52.17% |
| 2019 FY | - TWD | 117.0% |
| 2019 Q3 | 0.60 TWD | 46.34% |
| 2018 FY | - TWD | -45.65% |
| 2018 Q4 | 0.23 TWD | 130.0% |
| 2018 Q3 | 0.10 TWD | -66.67% |
| 2018 Q2 | 0.30 TWD | -18.92% |
| 2018 Q1 | 0.37 TWD | -27.45% |
| 2017 FY | - TWD | -18.22% |
| 2017 Q4 | 0.51 TWD | 54.55% |
| 2017 Q3 | 0.33 TWD | -5.71% |
| 2017 Q1 | 0.64 TWD | -5.88% |
| 2017 Q2 | 0.35 TWD | -45.31% |
| 2016 FY | - TWD | 3.69% |
| 2016 Q4 | 0.68 TWD | 61.9% |
| 2016 Q3 | 0.42 TWD | -16.0% |
| 2016 Q2 | 0.50 TWD | -23.08% |
| 2016 Q1 | 0.65 TWD | 16.07% |
| 2015 Q2 | 0.49 TWD | 16.67% |
| 2015 Q3 | 0.69 TWD | 40.82% |
| 2015 Q4 | 0.56 TWD | -18.84% |
| 2015 FY | - TWD | 185.53% |
| 2015 Q1 | 0.42 TWD | -14.29% |
| 2014 Q3 | 0.32 TWD | 45614.29% |
| 2014 Q1 | -0.06 TWD | -35.04% |
| 2014 FY | - TWD | 931.51% |
| 2014 Q4 | 0.49 TWD | 53.12% |
| 2014 Q2 | 0.00 TWD | 101.26% |
| 2013 Q2 | -0.10 TWD | -600.0% |
| 2013 Q4 | -0.04 TWD | -237.0% |
| 2013 FY | - TWD | -107.49% |
| 2013 Q1 | 0.02 TWD | 0.0% |
| 2013 Q3 | 0.03 TWD | 130.0% |
| 2012 Q1 | 0.32 TWD | 0.0% |
| 2012 Q2 | 0.46 TWD | 43.75% |
| 2012 FY | - TWD | 1120.0% |
| 2012 Q3 | 0.36 TWD | -21.74% |
| 2012 Q4 | - TWD | -100.0% |
| 2011 Q2 | - TWD | -100.0% |
| 2011 Q1 | 0.21 TWD | 0.0% |
| 2011 Q4 | - TWD | 0.0% |
| 2011 Q3 | - TWD | 0.0% |
| 2011 FY | - TWD | 158.82% |
| 2010 Q3 | - TWD | 0.0% |
| 2010 Q2 | - TWD | 100.0% |
| 2010 Q1 | -0.18 TWD | 0.0% |
| 2010 Q4 | - TWD | 0.0% |
| 2010 FY | - TWD | -185.0% |
| 2009 FY | - TWD | 0.0% |
| Name | Eps | Eps Difference |
|---|---|---|
| Maxigen Biotech Inc. | 1.86 TWD | -5.376% |
| SciVision Biotech Inc. | 2.66 TWD | 26.316% |
| Bionime Corporation | 0.10 TWD | -1860.0% |
| Pegavision Corporation | 22.83 TWD | 91.415% |
| Visco Vision Inc. | 4.79 TWD | 59.081% |